Last $4.67 USD
Change Today +0.41 / 9.62%
Volume 962.2K
As of 10:00 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William D. Baird III

Chief Financial Officer and Secretary, Amicus Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

42$787,029
As of Fiscal Year 2013

Background*

Mr. William D. Baird, III, also known as Chip, has been the Chief Financial Officer of Amicus Therapeutics, Inc. since April 16, 2012 and also serves as its Secretary. Mr. Baird served as the Chief Financial Officer of PTC Therapeutics Inc., from May 18, 2005 to June 3, 2013, and served as its Principal Accounting Officer until June 3, 2013. Mr. Baird served as Vice President of Finance and Strategic Planning of PTC Therapeutics Inc. Previously, Mr. Baird worked at L.E.K. ...

Read Full Background

Corporate Headquarters*

1 Cedar Brook Drive
Cranbury, New Jersey 08512

United States

Phone: 609-662-2000
Fax: 609-662-2001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
University of Pennsylvania - The Wharton School
BS
Georgetown University - Edmund A. Walsh School of Foreign Service

Other Affiliations*

Annual Compensation*

Salary$334,750
Bonus$110,334
Total Annual Compensation$445,084

Stock Options*

All Other Compensation$15,005
Exercisable Options91,656
Unexercisable Options286,344
Total Number of Options378,000

Total Compensation*

Total Annual Cash Compensation$460,089
Total Short Term Compensation$445,084
Other Long Term Compensation$15,005
Total Calculated Compensation$787,029
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FOLD:US $4.67 USD +0.41

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMICUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.